The respiratory inhaler devices market is a critical component of the global healthcare industry, focusing on devices designed to deliver medication directly to the lungs to treat respiratory diseases ...

The companion animal drugs market is estimated to reach USD 16,131.2 million in 2024. It is estimated that revenue will ...

However, by considering patients' individual circumstances and taking the time to ensure that they use the appropriate inhaler and technique, everyone can benefit. Asthma and COPD have a huge ...

Pharma major Lupin Ltd on Tuesday said it has partnered with Honeywell to use the latter’s propellant ‘Solstice Air’ to ...

Mepolizumab, a humanized monoclonal antibody that targets interleukin-5 (IL-5), significantly reduced COPD exacerbations in ...

The Trust Hospital has called for better access to inhaled medications for asthma patients in Ghana, joining the global ...

Speak to your healthcare professional about switching to a greener inhaler, and return unused or unwanted inhalers to your ...

That data can be used to check that a patient is using the correct technique to get a benefit from the inhaler, for example, and give patients and healthcare providers a view of how well they are ...

Inhaled insulin was noninferior to usual care in glycemic control outcomes after 17 weeks among patients with type 1 diabetes.

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of ...

Asthma is a chronic respiratory condition that affects around 300 million people worldwide, indicating just how widespread it ...

CHENNAI: The healthcare industry is increasingly integrating sustainability into its core strategies, with a growing emphasis on reducing environmental footprin ...